Loperamide
2011CB5200-Fd
Phase 3 small_molecule completed
Quick answer
Loperamide for Diarrhea-predominant Irritable Bowel Syndrome is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Diarrhea-predominant Irritable Bowel Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed